We are live on ! Find out more
DVC

Deer VII & Co Portfolio holdings

AUM $317M
1-Year Est. Return 30.89%
This Fund
S&P 500
This Quarter Est. Return
+23.96%
1 Year Est. Return
+30.89%
3 Year Est. Return
+241.3%
5 Year Est. Return
+1,036.06%
10 Year Est. Return
AUM
$31.8M
AUM Growth
-$4.13M
Cap. Flow
-$12M
Cap. Flow %
-37.77%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 61.63%
2 Technology 38.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNA
1
DELISTED
Allena Pharmaceuticals
ALNA
$15.9M 50.04%
2,263,365
DOCU
2
DocuSign
DOCU
$10.7B
$12.2M 38.37%
235,000
-235,000
-50% -$12M
VSTM icon
3
Verastem
VSTM
$547M
$3.52M 11.1%
99,197
TARA icon
4
Protara Therapeutics
TARA
$221M
$158K 0.5%
7,878

Similar funds

Deer VII & Co's Q1 2019 Portfolio in Review

As of Q1 2019, Deer VII & Co held 4 positions worth $31.8M, down 12% from $35.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Deer VII & Co withdrew a net $12M in Q1 2019, reducing 1 holding. Its largest reduction was DocuSign, cutting an estimated $12M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 48% a quarter earlier, followed by Technology.

  • Deer VII & Co's biggest Q1 2019 reduction was DocuSign, cutting an estimated $12M.
  • Deer VII & Co's ten largest holdings make up 100% of its $31.8M portfolio in Q1 2019.
  • Deer VII & Co opened 0 new positions and closed 0 in Q1 2019.
  • Deer VII & Co's portfolio value fell 12% quarter-over-quarter to $31.8M.

Based on Deer VII & Co's 13F filing for Q1 2019, filed 15 May 2019.